Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Clinical trial NCT07382817 · RECRUITING
Trial details
- NCT number
- NCT07382817
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-18
- Primary completion
- 2029-12-09
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.